Insertion of Totally Implantable Venous Access Devices: An Expertise-Based, Randomized, Controlled Trial (NCT00600444)
暂无分享,去创建一个
H. Kauczor | M. Büchler | C. Seiler | L. Fischer | M. Kieser | T. Bruckner | U. Stampfl | B. Radeleff | P. Knebel | R. López-Benítez | R. Hennes
[1] J. Eledjam,et al. Pulsed Doppler Ultrasonography Guidance for Catheterization of the Subclavian Vein: A Randomized Study , 1998, Anesthesiology.
[2] I. Di Carlo,et al. Increased Use of Percutaneous Technique for Totally Implantable Venous Access Devices. Is It Real Progress? A 27-Year Comprehensive Review on Early Complications , 2010, Annals of Surgical Oncology.
[3] T. Burke,et al. Outcome of 350 implanted chest ports placed by interventional radiologists. , 1997, Journal of vascular and interventional radiology : JVIR.
[4] Perry Ep,et al. Direct cephalic vein cannulation for safe subclavian access. , 1990 .
[5] R. Biffi,et al. Treatment of pneumothorax as a complication of long-term central venous port placement in oncology patients. An observational study. , 2001, The journal of vascular access.
[6] D. Hovsepian,et al. Interventional radiologic placement of chest wall ports: results and complications in 161 consecutive placements. , 1997, Journal of vascular and interventional radiology : JVIR.
[7] J. R. Nash,et al. Direct cephalic vein cannulation for safe subclavian access. , 1990, Journal of the Royal College of Surgeons of Edinburgh.
[8] Mohit Bhandari,et al. Randomized Controlled Trials of Surgical Interventions , 2010, Annals of surgery.
[9] I. Di Carlo,et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. , 2001 .
[10] D. Winchester,et al. Prospective, randomized trial of Doppler-assisted subclavian vein catheterization. , 1998, Archives of surgery.
[11] J. Niederhuber,et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. , 1982, Surgery.
[12] M. Büchler,et al. Randomized clinical trial of a modified Seldinger technique for open central venous cannulation for implantable access devices , 2009, The British journal of surgery.
[13] S. Povoski. A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients , 2000, Annals of Surgical Oncology.
[14] T. Chuter,et al. Placement of Hickman-Broviac catheters in the cephalic vein. , 1988, Surgery, gynecology & obstetrics.
[15] D. Conti,et al. Placement of a double lumen silastic catheter for hemodialysis access through the cephalic vein. , 1994, Journal of the American College of Surgeons.
[16] A. Toro,et al. External Jugular Vein Cutdown Approach, as a Useful Alternative, Supports the Choice of the Cephalic Vein for Totally Implantable Access Device Placement , 2005, Annals of Surgical Oncology.
[17] D. Wagner,et al. [The fluoroscopy-guided implantation of subcutaneous venous ports: the complications and long-term results]. , 1998, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[18] A. Kluge,et al. Durchleuchtungsgesteuerte Implantation subkutaner Venenports: Komplikationen und Langzeitergebnisse , 1998 .
[19] J. Olsen,et al. Long-term follow-up of upper extremity implanted venous access devices in oncology patients. , 1999, Journal of vascular and interventional radiology : JVIR.
[20] H. Kauczor,et al. Protocol of an expertise based randomized trial comparing surgical Venae Sectio versus radiological Puncture of Vena Subclavia for insertion of Totally Implantable Access Port in oncological patients , 2008, Trials.
[21] C. Seiler,et al. Surgical technique for totally implantable access ports (TIAP) needs improvement: A multivariate analysis of 400 patients , 2006, Journal of surgical oncology.
[22] H. Weiss,et al. Central Venous Access Ports Placed by Interventional Radiologists: Experience with 125 Consecutive Patients , 2001, CardioVascular and Interventional Radiology.
[23] V. Diehl,et al. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759] , 2005, BMC Cancer.
[24] F. Au. The anatomy of the cephalic vein. , 1989, The American surgeon.
[25] K. Rufibach,et al. Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports , 2009, The British journal of surgery.
[26] C. Seiler,et al. Reasons for Explantation of Totally Implantable Access Ports: A Multivariate Analysis of 385 Consecutive Patients , 2008, Annals of Surgical Oncology.
[27] J. le Saout,et al. [Anatomical basis for the surgical use of the cephalic vein (V. Cephalica). 74 anatomical dissections. 189 surgical dissections]. , 1983, Journal de chirurgie.
[28] J. L. Hernández,et al. The complications of central venous access systems: a study of 218 patients. , 1993, The European journal of surgery = Acta chirurgica.
[29] Daniel Hind,et al. Ultrasonic locating devices for central venous cannulation: meta-analysis , 2003, BMJ : British Medical Journal.
[30] Gordon H Guyatt,et al. Need for expertise based randomised controlled trials , 2005, BMJ : British Medical Journal.
[31] D. Radice,et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] P. Kienle,et al. Comparison of Venae Sectio vs. modified Seldinger Technique for Totally Implantable Access Ports; Portas-trial [ISRCTN:52368201] , 2006, Trials.
[33] J. Edney,et al. Insertion of Hickman catheters. A comparison of cutdown and percutaneous techniques. , 1984, The American surgeon.
[34] F. Orsi,et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.